Arlinda Lee – Canaccord Genuity

Canaccord Genuity

A Canaccord Genuity analyst with 10 tracked ratings across 9 distinct tickers has a 14.3% success rate on the captured sample, with all bullish ratings issued in one of the covered sources.

Aggregated from multiple market-data sources

Total ratings

Tickers covered

Sources

Aggregated

Latest rating

2 years ago

2023-09-07 00:00:00+00

Track record

Aggregated

14% success rate

Bullish: 0
Hold: 0
Bearish: 0

Aggregated

Not available

Bullish: 4
Hold: 0
Bearish: 0

Recent ratings

Ticker	Date	Rating	Price target	Source
DCTH	2023-09-07	buy	$21.00	Aggregated
DCTHDELCATH SYSTEMS INC	2023-09-07	unknown	$21.00	Aggregated
DCTH	2023-08-15	buy	$18.00	Aggregated
XFOR	2022-04-05	buy	$10.00	Aggregated
XFORX4 PHARMACEUTICALS INC	2022-04-05	unknown	$10.00	Aggregated
NKTRNEKTAR THERAPEUTICS	2022-03-16	unknown	$6.00	Aggregated
RYTMRHYTHM PHARMACEUTICALS INC.	2022-03-07	unknown	$36.00	Aggregated
CRSPCRISPR THERAPEUTICS AG	2021-08-16	unknown	$160.00	Aggregated
BCYCBICYCLE THERAPEUTICS PLC - ADR	2021-07-13	unknown	$36.00	Aggregated
AKTX	2018-03-29	buy	$8.00	Aggregated

Tickers covered(9)

Ticker	Ratings	Last rating	Sources
DCTH	2	2023-09-07	Aggregated
DCTHDELCATH SYSTEMS INC	1	2023-09-07	Aggregated
XFOR	1	2022-04-05	Aggregated
XFORX4 PHARMACEUTICALS INC	1	2022-04-05	Aggregated
NKTRNEKTAR THERAPEUTICS	1	2022-03-16	Aggregated
RYTMRHYTHM PHARMACEUTICALS INC.	1	2022-03-07	Aggregated
CRSPCRISPR THERAPEUTICS AG	1	2021-08-16	Aggregated
BCYCBICYCLE THERAPEUTICS PLC - ADR	1	2021-07-13	Aggregated
AKTX	1	2018-03-29	Aggregated

Methodology differs by source. Track records are aggregated from multiple sources; scoring methodology and scales differ by source and values are not directly comparable. Coverage is sourced from publicly-aggregated analyst activity. Past performance does not guarantee future results. Not investment advice.